Diabetes Core Update Special Edition: SGLT-2 inhibitors – Renal Effects– December 2020
In this second episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the renal effects of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association Guidelines and address practical issues about SGLT-2 inhibitor use. In episode 1, Drs. Russell and Skolnik discussed an overview of the CVOTs for the SGLT-2 inhibitors and in episode 3 they will focus heart failure outcomes. This special three-part series is supported by independent educational grant from AstraZeneca. For more information about each of ADA’s science and medical journals, pleas...
Source: Diabetes Core Update - December 3, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update – December 2020
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - November 24, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update: COVID-19 – Town Hall -- Inpatient Managment for People with Diabetes and COVID-19, October 2020
This special issue focuses on inpatient management of People with Diabetes and COVID-19 answering questions from a large online audience as a launching point for discussion. Recorded Oct 13, 2020 This is a part of the American Diabetes Associations ongoing project providing resources for practicing clinicians on the care of Diabetes during the Covid-19 pandemic. Today’s discussion is an audio version of a webinar recorded on May 14, 2020. Presented by: Robert A. Gabbay, MD, PhD American Diabetes Association Joseph A. Aloi, MD Wake Forest Baptist Health Amisha Wallia, MD Northwestern Memorial Hospital Rodolfo Galindo...
Source: Diabetes Core Update - November 11, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update: Therapeutic Inertia Part 3 – November 2020
In this third episode of a three-part series on “Disrupting Therapeutic Inertia in Diabetes Management,” we discuss practical advice about how to combat therapeutic inertia in the office with four clinical experts. This special three-part series on therapeutic inertia is supported by independent educational grant from Sanofi (https://www.sanofi.com). For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, ...
Source: Diabetes Core Update - November 6, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update – November 2020
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - October 26, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update – October 2020
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - October 11, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update: Influenza and Diabetes Part 2 – September 2020
In this second episode of the three-part series “Influenza and Diabetes,” Drs. John Russell and Neil Skolnik discuss the consequences of influenza for persons with diabetes, the specific benefits of influenza vaccination in persons with diabetes - including new information on the cardiovascular benefits of influenza vaccination in diabetes - and discuss the details of currently available vaccine choices. This special three-part series is supported by independent educational grant from Sanofi Pasteur. For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Pr...
Source: Diabetes Core Update - September 29, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Hypertension, Obesity, and COVID-19
New data show unfavorable US trends in hypertension and obesity, with communities of color doing worse. National Institute of Diabetes and Digestive and Kidney Diseases Director Griffin P. Rodgers, MD, and National Heart, Lung, and Blood Institute Director Gary H. Gibbons, MD, discuss the implications for COVID-19 outcomes and public health. Recorded September 10, 2020. Related Article(s): Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018 (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 14, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Diabetes Core Update: SGLT-2 inhibitors – Cardiovascular Effects– Sept. 2020
In this first episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the Cardiovascular Outcome Trials (CVOTs) of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association Guidelines and answer some common practical questions about SGLT-2 inhibitor use. In episodes 2 and 3 of this series, Drs. Russell and Skolnik we will discuss the evidence about the effects of the SGLT-2 inhibitors on renal and heart failure outcomes. This special episode of the Diabetes Core Update was supported by an unrestricted educational grant from the Division...
Source: Diabetes Core Update - September 11, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Talking about obesity with Stephanie DiGirogio and Naveen Sattar
Fatphobia has been described as society ’s last ‘ism’. Whilst our understanding of weight and health has changed over time, there is still a stigma towards people who are overweight or obese, and an assumption that they must be unhealthy, and unhealthy by choice. However, the correlation between weight and health may not be as clear cut as our societal biases would lead us to believe, and, therefore, the challenge for GPs is to make a conscious efforts to overcome our preconceptions so that they may provide the best support for our obese patients. This week, we discuss the need for a zero tolerance towards fat shamin...
Source: The BMJ Podcast - September 10, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talking about obesity with Stephanie deGiorgio and Naveed Sattar
Fatphobia has been described as society ’s last ‘ism’. Whilst our understanding of weight and health has changed over time, there is still a stigma towards people who are overweight or obese, and an assumption that they must be unhealthy, and unhealthy by choice. However, the correlation between weight and health may not be as clear cut as our societal biases would lead us to believe, and, therefore, the challenge for GPs is to make a conscious efforts to overcome our preconceptions so that they may provide the best support for our obese patients. This week, we discuss the need for a zero tolerance towards fat shamin...
Source: The BMJ Podcast - September 10, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talking about obesity with Stephanie deGiorgio and Naveed Sattar
Fatphobia has been described as society’s last ‘ism’. Whilst our understanding of weight and health has changed over time, there is still a stigma towards people who are overweight or obese, and an assumption that they must be unhealthy, and unhealthy by choice. However, the correlation between weight and health may not be as clear cut as our societal biases would lead us to believe, and, therefore, the challenge for GPs is to make a conscious efforts to overcome our preconceptions so that they may provide the best support for our obese patients. This week, we discuss the need for a zero tolerance towards fat shaming...
Source: The BMJ Podcast - September 10, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts
FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - September 8, 2020 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
